title: FOLFIRI with cetuximab or bevacizumab: FIRE-3.
authors.affiliation: Medical Oncology Unit, Oncology Department, Azienda Ospedaliera Treviglio, 24047 Treviglio, Italy. Electronic address: faupe@libero.it.
authors.forename: Fausto
authors.initials: F
authors.lastname: Petrelli
authors.affiliation: Medical Oncology Unit, Oncology Department, Azienda Ospedaliera Treviglio, 24047 Treviglio, Italy.
authors.forename: Andrea
authors.initials: A
authors.lastname: Coinu
authors.affiliation: Medical Oncology Unit, Oncology Department, Azienda Ospedaliera Treviglio, 24047 Treviglio, Italy.
authors.forename: Sandro
authors.initials: S
authors.lastname: Barni
mesh_terms: D061067:Antibodies, Monoclonal, Humanized / Q000627:therapeutic use*; D000971:Antineoplastic Combined Chemotherapy Protocols / Q000627:therapeutic use*; D002166:Camptothecin / Q000031:analogs & derivatives*; D015179:Colorectal Neoplasms / Q000188:drug therapy* / Q000473:pathology*; D005260:Female; D006801:Humans; D008297:Male
chemical_list: D061067:Antibodies, Monoclonal, Humanized; D002166:Camptothecin